Clinical Improvement
Clinical Improvement - Related Videos
12:08
Improving IV Insulin Administration in a Community Hospital
0 Views •
Cited by 7 •
2012
When compared to the previous paper protocol, implementation of a computerized glucose management system results in a substantial increase in blood glucose concentration measurements within the target range. Using a computerized glucose management system to monitor blood glucose levels, decreases in severe hypoglycemia (<40 mg/dL), clinical hypoglycemia (<70 mg/dL), and hyperglycemia (>180 mg/dL) also can be observed.
05:40
Handheld Device for Saliva Pretreatment to Improve Cortisol Detection
0 Views •
2026
This protocol describes a rapid saliva pretreatment method for improving cortisol detection. A handheld filtration device is used to remove mucins and other interfering substances while preserving the target analyte. The pretreated saliva exhibits improved capillary flow, thereby enabling more consistent and reproducible assay performance.
07:50
Establishment of a Clinic-based Biorepository
0 Views •
Cited by 4 •
2017
Cutaneous tumors are often discarded following Mohs micrographic surgery. A protocol is described here that enables clinical support staff to effectively process and store cutaneous tumor (e.g., squamous cell carcinoma, basal cell carcinoma, and melanoma) samples for downstream laboratory applications without interfering with clinical operations.
09:05
Determining the Phagocytic Activity of Clinical Antibody Samples
0 Views •
Cited by 33 •
2011
We present a high-throughput flow cytometric assay to determine the phagocytic activity of antigen-specific antibodies from clinical samples, utilizing fluorescent antigen-coated beads and a monocytic cell line expressing multiple Fc receptors—providing receptor usage and phagocytic activity determinations in a standardized and reproducible fashion for any antigen of interest.
14:37
Accessibility to Clinical Care for People who use Wheelchairs
0 Views •
2023
Source: Yetsa Tuakli-Wosornu1,2, Jaideep Talwalkar1; 1Yale School of Medicine, 2University of Pittsburgh In the United States, 25% of the general population suffers from one or another type of disability. Ambulatory disabilities, or mobility impairments, represent the most common subcategory, comprising 14% of the country's populace. Different mobility-assistive devices, ranging from canes to scooters, enable increased independence and improved quality of life for those suffering from mobility...
FAQs
Clinicians and researchers track change by comparing validated clinical measures at multiple time points. These measures can show whether symptoms decline or daily functioning improves after an intervention, rather than relying on a single observation. Repeated assessment also helps connect a patient’s reported or observed progress with treatment evaluation and longer-term care decisions.
Several biological routes may accompany better clinical outcomes. Neural plasticity can support changes in nervous-system function, restored circuit activity can improve the operation of affected networks, reduced inflammation can lessen a damaging biological influence, and unaffected brain regions may compensate for impaired areas. These possibilities help neuroscience relate observable recovery to underlying changes, without assuming one mechanism explains every case.
An apparent gain may not represent durable or meaningful recovery. Clinical improvement must be interpreted in relation to temporary symptom fluctuations and to whether health and daily function actually improve. This distinction matters because a change that appears favorable on a short-term measure may not translate into better quality of life. It supports more careful evaluation of intervention outcomes.
To evaluate an intervention, researchers compare validated clinical measures over time and examine whether changes correspond to symptom relief or improved daily function. They can then relate these patient-level outcomes to proposed neural explanations, such as plasticity or restored circuit activity. This workflow helps test whether biological findings have practical significance for people receiving care.
Clinical improvement serves as a key outcome when treatments are studied for neurological and psychiatric disorders. Tracking symptom and functional changes allows investigators to judge whether an intervention benefits patients, while comparison with biological mechanisms can clarify how that benefit may arise. The same evidence can guide refinement of care rather than treating a laboratory change as sufficient on its own.
Findings about improvement can support individualized care because patients may reach better function through different biological routes. One person’s progress might be associated with restored circuit activity, whereas another may rely more on compensation by unaffected brain regions. Monitoring validated clinical measures helps clinicians focus on the patient’s actual symptoms and functioning when refining care.